Montreal, November 28, 2025 – CQDM is proud to have presented the 2025 RSRI Innovation Award at the ADRIQ Innovation Awards Gala to Philippe Joubert, Yohan Bossé, Solutions de diagnostic BioMark, and their valued collaborators! They are being recognized for a collaborative project that is transforming lung cancer screening in Quebec. 🏆
Supported by CQDM and MEIE, this $4.42M project is the result of an exemplary collaboration between IUCPQ-UL (Philippe Joubert, Yohan Bossé, and their collaborators), BioMark Diagnostic Solutions, the IUCPQ Foundation, AstraZeneca, and Pfizer.
This collaborative R&D project, with a total value of $4.42M, was made possible thanks to funding from the Quebec government, administered by CQDM. It brings together numerous committed partners: IUCPQ-UL, Solutions de diagnostic BioMark, AstraZeneca Canada, Pfizer Canada, and the IUCPQ Foundation. The project has achieved a simpler, faster, more affordable, and less invasive lung cancer screening test, thanks to a metabolomics-based approach.
The project has also created numerous jobs, trained highly qualified scientific talent, and strengthened expertise in cutting-edge fields. It has stimulated the growth of BioMark, which secured an additional $4.85M in investments, and enabled the research team to obtain $1.2M in grants, while fostering strategic synergies between the public and private sectors.
Discover the full story of this success and the opportunities it opens for the health of Quebecers:
Photos from the RSRI Innovation Award 2025 ceremony
